
Lei Yao
Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1328 |
| Issued Applications | 662 |
| Pending Applications | 127 |
| Abandoned Applications | 552 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11845698
[patent_doc_number] => 09733249
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-15
[patent_title] => 'MPL mutations in JAK2 V617F negative patients with myeloproliferative disease'
[patent_app_type] => utility
[patent_app_number] => 14/492822
[patent_app_country] => US
[patent_app_date] => 2014-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11343
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14492822
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/492822 | MPL mutations in JAK2 V617F negative patients with myeloproliferative disease | Sep 21, 2014 | Issued |
Array
(
[id] => 11401750
[patent_doc_number] => 20170022288
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2017-01-26
[patent_title] => 'PANCREATIC CANCER ASSOCIATED ANTIGEN, ANTIBODY THERETO, AND DIAGNOSTIC AND TREATMENT METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/492408
[patent_app_country] => US
[patent_app_date] => 2014-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 25433
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14492408
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/492408 | PANCREATIC CANCER ASSOCIATED ANTIGEN, ANTIBODY THERETO, AND DIAGNOSTIC AND TREATMENT METHODS | Sep 21, 2014 | Abandoned |
Array
(
[id] => 11401750
[patent_doc_number] => 20170022288
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2017-01-26
[patent_title] => 'PANCREATIC CANCER ASSOCIATED ANTIGEN, ANTIBODY THERETO, AND DIAGNOSTIC AND TREATMENT METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/492408
[patent_app_country] => US
[patent_app_date] => 2014-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 25433
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14492408
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/492408 | PANCREATIC CANCER ASSOCIATED ANTIGEN, ANTIBODY THERETO, AND DIAGNOSTIC AND TREATMENT METHODS | Sep 21, 2014 | Abandoned |
Array
(
[id] => 10202744
[patent_doc_number] => 20150087728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/491446
[patent_app_country] => US
[patent_app_date] => 2014-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 31089
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14491446
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/491446 | COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER | Sep 18, 2014 | Abandoned |
Array
(
[id] => 11016801
[patent_doc_number] => 20160213754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'TRANSGLUTAMINASE 4 AS A PROSTATE SPECIFIC AUTOANTIGEN AND THE METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/023434
[patent_app_country] => US
[patent_app_date] => 2014-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10133
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15023434
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/023434 | TRANSGLUTAMINASE 4 AS A PROSTATE SPECIFIC AUTOANTIGEN AND THE METHODS OF USE THEREOF | Sep 17, 2014 | Abandoned |
Array
(
[id] => 9792215
[patent_doc_number] => 20150004159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'SCREENING FOR ANTI-CANCER COMPOUNDS USING NETRIN-1 ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/486124
[patent_app_country] => US
[patent_app_date] => 2014-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 17485
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14486124
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/486124 | SCREENING FOR ANTI-CANCER COMPOUNDS USING NETRIN-1 ACTIVITY | Sep 14, 2014 | Abandoned |
Array
(
[id] => 16742029
[patent_doc_number] => 10966998
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => Cancer therapy via a combination of epigenetic modulation and immune modulation
[patent_app_type] => utility
[patent_app_number] => 14/916235
[patent_app_country] => US
[patent_app_date] => 2014-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 22820
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14916235
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/916235 | Cancer therapy via a combination of epigenetic modulation and immune modulation | Sep 4, 2014 | Issued |
Array
(
[id] => 11054474
[patent_doc_number] => 20160251437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'METHODS FOR TREATING CANCER IN PATIENTS WITH ELEVATED LEVELS OF BIM'
[patent_app_type] => utility
[patent_app_number] => 15/026461
[patent_app_country] => US
[patent_app_date] => 2014-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 13037
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15026461
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/026461 | Methods for treating cancer in patients with elevated levels of BIM | Sep 2, 2014 | Issued |
Array
(
[id] => 13287711
[patent_doc_number] => 10155028
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-18
[patent_title] => Method for prophylaxis and/or treatment of ErbB2 positive cancers
[patent_app_type] => utility
[patent_app_number] => 14/913515
[patent_app_country] => US
[patent_app_date] => 2014-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 18096
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14913515
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/913515 | Method for prophylaxis and/or treatment of ErbB2 positive cancers | Aug 19, 2014 | Issued |
Array
(
[id] => 11002538
[patent_doc_number] => 20160199487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'MODULATION OF TUMOR IMMUNITY'
[patent_app_type] => utility
[patent_app_number] => 14/912733
[patent_app_country] => US
[patent_app_date] => 2014-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15425
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14912733
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/912733 | Modulation of tumor immunity | Aug 17, 2014 | Issued |
Array
(
[id] => 14759533
[patent_doc_number] => 10391146
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-27
[patent_title] => Method to functionalize cells in human blood, other fluids and tissues using nanoparticles
[patent_app_type] => utility
[patent_app_number] => 14/909523
[patent_app_country] => US
[patent_app_date] => 2014-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 15983
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14909523
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/909523 | Method to functionalize cells in human blood, other fluids and tissues using nanoparticles | Aug 3, 2014 | Issued |
Array
(
[id] => 9896180
[patent_doc_number] => 20150051379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-19
[patent_title] => 'METHOD FOR TREATING SYNOVIAL SARCOMA'
[patent_app_type] => utility
[patent_app_number] => 14/447122
[patent_app_country] => US
[patent_app_date] => 2014-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 29447
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14447122
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/447122 | Method for treating synovial sarcoma | Jul 29, 2014 | Issued |
Array
(
[id] => 10926227
[patent_doc_number] => 20140329248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-06
[patent_title] => 'B7-H1 AND SURVIVIN IN CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/328367
[patent_app_country] => US
[patent_app_date] => 2014-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8197
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14328367
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/328367 | B7-H1 AND SURVIVIN IN CANCER | Jul 9, 2014 | Abandoned |
Array
(
[id] => 10800683
[patent_doc_number] => 20160146840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'AUGURIN IMMUNOASSAY'
[patent_app_type] => utility
[patent_app_number] => 14/903893
[patent_app_country] => US
[patent_app_date] => 2014-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11462
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14903893
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/903893 | Augurin immunoassay | Jul 9, 2014 | Issued |
Array
(
[id] => 9798641
[patent_doc_number] => 20150010585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-08
[patent_title] => 'IMMUNOCONJUGATES TARGETING SYNDECAN-1 EXPRESSING CELLS AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/327888
[patent_app_country] => US
[patent_app_date] => 2014-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14311
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14327888
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/327888 | IMMUNOCONJUGATES TARGETING SYNDECAN-1 EXPRESSING CELLS AND USE THEREOF | Jul 9, 2014 | Abandoned |
Array
(
[id] => 12166950
[patent_doc_number] => 09885718
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-06
[patent_title] => 'Specific biomarker set for non-invasive diagnosis of liver cancer'
[patent_app_type] => utility
[patent_app_number] => 14/321870
[patent_app_country] => US
[patent_app_date] => 2014-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 13
[patent_no_of_words] => 5373
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14321870
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/321870 | Specific biomarker set for non-invasive diagnosis of liver cancer | Jul 1, 2014 | Issued |
Array
(
[id] => 11298921
[patent_doc_number] => 09506925
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-29
[patent_title] => 'Specific biomarker set for non-invasive diagnosis of liver cancer'
[patent_app_type] => utility
[patent_app_number] => 14/321867
[patent_app_country] => US
[patent_app_date] => 2014-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 13
[patent_no_of_words] => 5372
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 310
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14321867
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/321867 | Specific biomarker set for non-invasive diagnosis of liver cancer | Jul 1, 2014 | Issued |
Array
(
[id] => 9771798
[patent_doc_number] => 20140295459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'MARKERS FOR IDENTIFYING TUMOR CELLS, METHODS AND KIT THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/304432
[patent_app_country] => US
[patent_app_date] => 2014-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15791
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14304432
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/304432 | MARKERS FOR IDENTIFYING TUMOR CELLS, METHODS AND KIT THEREOF | Jun 12, 2014 | Abandoned |
Array
(
[id] => 9737500
[patent_doc_number] => 20140273217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'PRODRUG ACTIVATION IN CANCER CELLS USING MOLECULAR SWITCHES'
[patent_app_type] => utility
[patent_app_number] => 14/291925
[patent_app_country] => US
[patent_app_date] => 2014-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 27497
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14291925
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/291925 | Prodrug activation in cancer cells using molecular switches | May 29, 2014 | Issued |
Array
(
[id] => 10763300
[patent_doc_number] => 20160109455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'COMPOSITIONS FOR OVARIAN CANCER ASSESSMENT HAVING IMPROVED SPECIFICTY'
[patent_app_type] => utility
[patent_app_number] => 14/890091
[patent_app_country] => US
[patent_app_date] => 2014-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 70
[patent_figures_cnt] => 70
[patent_no_of_words] => 23092
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14890091
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/890091 | COMPOSITIONS FOR OVARIAN CANCER ASSESSMENT HAVING IMPROVED SPECIFICTY | May 7, 2014 | Abandoned |